Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2010
04/13/2010CA2486001C Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
04/13/2010CA2415076C Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
04/13/2010CA2407683C Topical anesthetic/opioid formulations and uses thereof
04/13/2010CA2394165C Drospirenone for hormone replacement therapy
04/13/2010CA2381741C Directly compressible raw material for compressed products
04/13/2010CA2380805C Improved topical medicaments and methods for photodynamic treatment of disease
04/13/2010CA2331527C Biologically active composition
04/13/2010CA2321268C Liquid crystal forms of cyclosporin
04/13/2010CA2293484C Dispenser with doses counter
04/13/2010CA2290664C Compounds, preparation and use for transferring nucleic acids into cells
04/13/2010CA2203528C Methods and kits using macrophage stimulating protein
04/09/2010CA2682086A1 Micronized composition of a 2,4-disubstituted phenol derivative
04/08/2010WO2010040057A1 Modified calcium phosphate nanoparticle formation
04/08/2010WO2010040055A2 Oral pharmaceutical formulations for antidiabetic compounds
04/08/2010WO2010039890A1 Benign solvents for forming protein structures
04/08/2010WO2010039798A2 Amorphous compositions of sunitinib base and l-malic acid
04/08/2010WO2010039762A2 Pharmaceutical compositions comprising boronic acid compounds
04/08/2010WO2010039722A1 Implantable device for the delivery of risperidone and methods of use thereof
04/08/2010WO2010039717A1 Implantable device for the delivery of octreotide and methods of use thereof
04/08/2010WO2010039643A1 Implantable device for the delivery of histrelin and methods of use thereof
04/08/2010WO2010039641A2 Long term drug delivery devices with polyurethane-based polymers and their manufacture
04/08/2010WO2010039575A1 Granular composition
04/08/2010WO2010039560A2 Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
04/08/2010WO2010039496A2 Nanocarriers for drug delivery
04/08/2010WO2010039490A2 Composition and method for preparing stable unilamellar liposomal suspension
04/08/2010WO2010039381A1 Transdermal extended-delivery donepezil compositions and methods for using the same
04/08/2010WO2010039054A1 Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis
04/08/2010WO2010039048A1 Compositions and methods for treatment of radiation exposure
04/08/2010WO2010039039A1 Oral formulations of gemcitabine derivatives
04/08/2010WO2010039036A1 Double emulsion and method to produce such
04/08/2010WO2010039007A2 Solid microstructure that enables multiple controlled release and method of manufacturing same
04/08/2010WO2010039006A2 Method of manufacturing solid microstructure and solid microstructure manufactured based on same
04/08/2010WO2010038747A1 Hydrophilic material, medical material and sustained release pharmaceutical material
04/08/2010WO2010038695A1 Compression-molded preparation and method for producing the same
04/08/2010WO2010038691A1 Particulate pharmaceutical composition for oral administration
04/08/2010WO2010038689A1 Pharmaceutical composition for oral administration
04/08/2010WO2010038688A1 Particulate pharmaceutical composition for oral administration of atorvastatin
04/08/2010WO2010038647A1 Adhesive patch and adhesive patch kit
04/08/2010WO2010038241A2 Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid
04/08/2010WO2010038234A1 Combination product of spironolactone and doxycycline
04/08/2010WO2010038129A1 Mucomimetic compositions and uses therefore
04/08/2010WO2010037878A1 Utilisation of nanoparticles of noble metals as immunomodulators and immunomodulator composition
04/08/2010WO2010037854A2 Alcohol-resistant tablet
04/08/2010WO2010037849A1 Duloxetine enteric pellets
04/08/2010WO2010037845A1 Inhalable particles comprising tiotropium
04/08/2010WO2010037753A1 New controlled release active agent carrier
04/08/2010WO2010037728A2 Novel ezetimibe formulations
04/08/2010WO2010037695A1 Enzyme composition and application thereof in the treatment of pancreatic insufficiency
04/08/2010WO2010037566A1 Improved nanoparticulate compositions of poorly soluble compounds
04/08/2010WO2010037543A1 Lipid pellets with enhanced taste-masking
04/08/2010WO2010037256A1 Composition for reducing blood fat and blood glucose
04/08/2010WO2010011289A3 Parenteral and oral formulations of benzimidazoles
04/08/2010WO2010003465A3 A drug powder for inhalation administration and a process thereof
04/08/2010WO2009155488A3 Novel oxalate salt and crystal of o-desmethylvenlafaxine
04/08/2010WO2009155397A3 Edible holographic silk products
04/08/2010WO2009129509A4 Methods and compositions for treating post-operative pain comprising a local anesthetic
04/08/2010WO2009129453A4 Clonidine formulation in a polyorthoester carrier
04/08/2010WO2009129437A4 Methods and compositions for treating post-operative pain comprising clonidine
04/08/2010WO2009050291A3 Solid dispersion product of n-aryl urea-based drugs
04/08/2010WO2009002490A3 Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide
04/08/2010US20100087768 Transdermal drug delivery system for liquid active ingredient
04/08/2010US20100087547 Use of a Blood-Flow Decrease Preventing Agent in Conjunction With Insufflating Gas
04/08/2010US20100087474 Materials and methods for enhanced degradation of mutant proteins associated with human disease
04/08/2010US20100086624 Colon cleansing compositions and methods
04/08/2010US20100086615 Agent for treatment of pulmonary disease
04/08/2010US20100086614 Nanoparticulated anesthetic composition for topic use
04/08/2010US20100086613 Chitosan vehicle and method for making same
04/08/2010US20100086612 Coated carriers
04/08/2010US20100086611 Method for Treating Infectious Organisms Normally Considered to be Resistant to an Antimicrobial Drug
04/08/2010US20100086610 Vault and vault-like carrier molecules
04/08/2010US20100086609 Methods and Compositions for Delivering Peptides
04/08/2010US20100086608 Methods and Devices for Detecting Binding Events via Zeta-Potential and Pharmacologically Active Compounds and Delivery Systems Identified Thereby
04/08/2010US20100086607 Self-Assembled Biodegradable Nanoparticles for Medical and Biological Applications
04/08/2010US20100086606 Active Agent Loaded Uniform, Rigid, Spherical, Nanoporous Calcium Phosphate Particles and Methods of Making and Using the Same
04/08/2010US20100086605 Material, item and products comprising a composition having anti-microbial properties
04/08/2010US20100086604 Absorbant superhydrophobic materials, and methods of preparation and use thereof
04/08/2010US20100086602 Pharmaceutical composition containing statin-encapsulated nanoparticle
04/08/2010US20100086601 Modified Calcium Phosphate Nanoparticle Formation
04/08/2010US20100086600 Flowable Carrier Matrix
04/08/2010US20100086599 Oral modified release formulations
04/08/2010US20100086598 Traversal of nucleic acid molecules through a fluid space and expression in repair cells
04/08/2010US20100086597 Microspheres for the sustained release of octreotide with a low initial burst
04/08/2010US20100086596 Microspheres for releasing an octreotide compound without an initial time lag
04/08/2010US20100086595 Non-ionizable hydrophobic galenical system
04/08/2010US20100086594 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
04/08/2010US20100086593 Dosage forms of bisphosphonates
04/08/2010US20100086592 Modified dosage forms of tacrolimus
04/08/2010US20100086591 Rapidly Disintegrating Dosage Form
04/08/2010US20100086590 Novel stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
04/08/2010US20100086589 Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
04/08/2010US20100086588 Compositions and methods for treatment of bowel diseases with granulated mesalamine
04/08/2010US20100086587 Hard shell capsule formulations
04/08/2010US20100086586 Pharmaceutical Composition
04/08/2010US20100086585 Antinuclear antibody utilized as a targeting agent for pharmaceutical compounds used in the treatment of cancer and other diseases
04/08/2010US20100086584 VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES
04/08/2010US20100086583 Lipid-analogous phosphoric triesters
04/08/2010US20100086582 Amorphous rotigotine transdermal system
04/08/2010US20100086581 Method for purpura reduction and prevention
04/08/2010US20100086579 Macrocyclic lactone compounds and methods for their use
04/08/2010US20100086573 Composition and method for preparing stable unilamellar liposomal suspension
1 ... 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 ... 2991